With direct letters, regulatory comments and other activities, Vizient strives to form constructive relationships with lawmakers, regulatory agencies and administration officials, to provide a unified voice on issues that have a direct impact on our members.
2026 Advocacy
- April 6 – Vizient comments to Office of the National Coordinator for Health Information Technology Policy (ONC) on United States Core Data for Interoperability Draft Version 7
- March 30 – Vizient comments to the Centers for Medicare and Medicaid Services (CMS) on the Advanced Notice of Proposed Rulemaking (ANPRM): Medicare Program; Ensuring Safety through Domestic Security with Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement
- March 13 – Vizient comments to the Centers for Medicare and Medicaid Services (CMS) on the Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027 proposed rule
- February 23 – Vizient comments to the Centers for Medicare and Medicaid Services (CMS) on the Global Benchmark for Efficient Drug Pricing (GLOBE) Model proposed rule
- January 26 – Vizient comments to the Centers for Medicare and Medicaid Services (CMS) on Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program
- January 6 - Vizient comments to the Partnership for Quality Management (P4QM) on the 2025 Measures Under Consideration (MUC) List
- January 6 - Vizient comments to the Food and Drug Administration (FDA) on draft guidance for industry, “Scientific Considerations in Demonstrating Biosimilarity to a Reference Product: Updated Recommendations for Assessing the Need for Comparative Efficacy Studies”
Connect with Vizient to help you solve health care’s biggest challenges